[Report Description]
“The global stem cell banking market projected to grow at a CAGR of 8.2%.”
The global stem cell banking market is projected to reach USD 9.30 billion by 2023 from 6.28 billion in 2018, at a CAGR of 8.2%. Stem cell banking market growth is mainly driven by the factors such as public awareness related to the therapeutic potential of stem cells; development of novel technologies for stem cell preservation, processing, and storage; rising number of hematopoietic stem cell transplantations (HSCTs); and increasing number of stem cell-based research. However, the high operational costs associated with stem cell banking and stringent regulatory frameworks are expected to limit the growth of the stem cell banking market during the forecast period.
“The placental stem cells segment is poised to be the fastest-growing source in stem cell banking market during the forecast period.”
Based on source, the stem cell banking market is segmented into placental, bone marrow-derived, adipose tissue-derived, human embryo-derived, dental pulp, and other stem cell sources. The placental stem cells segment is projected to grow at the highest rate during the forecast period; owing to the global rise in the number of placental and cord banks (especially in the US and Europe) coupled with growing public awareness about the therapeutic potential of stem cells.
“Asia Pacific is expected to register the highest growth rate during the forecast period.”
Geographically, the stem cell banking market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Asia Pacific is expected to register the highest CAGR during the forecast period due to the growing number of stored units with public & private stem cell banks; supportive regulatory framework for stem cell collection, processing, and preservation across major Asian countries; increased collaborations & partnerships between stem cell banking service providers to expand their networks across emerging countries; rising public awareness about the clinical benefits of stem cell therapies; and ongoing expansion & modernization of healthcare infrastructure.
Breakdown of supply-side primary interviews: by company type, designation, and region:
• By Company Type - Tier 1 – 12%, Tier 2 – 48% and Tier 3 – 40%
• By Designation – C-level – 26%, Director-level – 30%, Others – 44%
• By Region – North America - 34%, Europe – 26%, APAC – 23%, RoW – 17%
The global stem cell banking market is an expanding industry segment with a growing number of global and local service providers. As of 2017, the global stem cell banking market was dominated by Cord Blood Registry (CBR) Systems (US), Cordlife Group Limited (Singapore), and Cryo-Cell International (US). Service launches & upgrades; agreements, partnerships, & collaborations; and mergers & acquisitions were the major strategies adopted by majority of the market players to sustain their market position in the global stem cell banking market.
Research Coverage
This report studies the global stem cell banking market based on source, application, and service type. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes opportunities and challenges in the market for key stakeholders and provides details of the competitive landscape for the market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.
Reasons to Buy the Report:
From an insights perspective, this research report has focused on various levels of analysis—industry trends, market ranking analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the global stem cell banking market, and high-growth regions & countries and their respective drivers, restraints, challenges, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the global stem cell banking market, which in turn help service providers garner greater market shares. Firms purchasing the report could use any one or a combination of the below mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on service portfolios offered by the major players in the global stem cell banking industry. The report analyzes the global stem cell banking market based on source, application, service type, and region/country
• Product Development: Detailed insights on the research and development activities and new service offering/upgradation in the global stem cell banking market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market opportunities for various stem cell banking services across key geographies.
• Market Diversification: Exhaustive information about new service offerings, untapped geographies, recent developments, and investments in the global stem cell banking market
• Competitive Assessment: In-depth assessment of market ranking, major strategies, service offerings, and geographic coverage of leading players in the global stem cell banking market
TABLE OF CONTENTS
1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.2.1 MARKETS COVERED 15
1.2.2 GEOGRAPHIC SCOPE 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 16
1.3 CURRENCY USED 17
1.4 MARKET STAKEHOLDERS 17
2 RESEARCH METHODOLOGY 18
2.1 RESEARCH DATA 18
2.1.1 SECONDARY DATA 19
2.1.1.1 Secondary sources 20
2.1.2 PRIMARY DATA 21
2.1.2.1 Breakdown of primaries 21
2.1.2.2 Key data from primary sources 22
2.2 MARKET SIZE ESTIMATION 22
2.2.1 BOTTOM-UP APPROACH 23
2.2.2 TOP-DOWN APPROACH 24
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 25
2.4 RESEARCH ASSUMPTIONS 26
2.5 RESEARCH LIMITATIONS 26
3 EXECUTIVE SUMMARY 27
4 PREMIUM INSIGHTS 31
4.1 STEM CELL BANKING: MARKET OVERVIEW (2018) 31
4.2 STEM CELL BANKING MARKET, BY SOURCE (2018 VS. 2023) 32
4.3 STEM CELL BANKING MARKET, BY APPLICATION (2018 VS. 2023) 33
4.4 STEM CELL BANKING MARKET, BY SERVICE TYPE (2018 VS. 2023) 33
4.5 GEOGRAPHIC SNAPSHOT: STEM CELL BANKING MARKET (2018) 34
5 MARKET OVERVIEW 35
5.1 INTRODUCTION 35
5.2 MARKET DYNAMICS 35
5.2.1 MARKET DRIVERS 36
5.2.1.1 Growing awareness on the therapeutic potential of stem cells 36
5.2.1.2 Development of novel technologies for stem cell preservation, processing, and storage 36
5.2.1.3 Increase in hematopoietic stem cell transplantation procedures 37
5.2.1.4 Increasing investments in stem cell-based research 37
5.2.2 MARKET RESTRAINTS 38
5.2.2.1 High operational costs of stem cell banking 38
5.2.2.2 Stringent regulatory frameworks 38
5.2.3 MARKET OPPORTUNITIES 39
5.2.3.1 Emerging countries 39
5.2.3.2 Rising global burden of major diseases 40
5.2.4 MARKET CHALLENGE 40
5.2.4.1 Socio-ethical concerns related to embryonic stem cells 40
6 STEM CELL BANKING MARKET, BY SOURCE 41
6.1 INTRODUCTION 42
6.2 PLACENTAL STEM CELLS (PSCS) 43
6.3 ADIPOSE TISSUE-DERIVED STEM CELLS (ADSCS) 44
6.4 BONE MARROW-DERIVED STEM CELLS (BMSCS) 45
6.5 HUMAN EMBRYO-DERIVED STEM CELLS (HESCS) 46
6.6 DENTAL PULP-DERIVED STEM CELLS (DPSCS) 47
6.7 OTHER STEM CELL SOURCES 48
7 STEM CELL BANKING MARKET, BY SERVICE TYPE 49
7.1 INTRODUCTION 50
7.2 SAMPLE PRESERVATION AND STORAGE 51
7.3 SAMPLE ANALYSIS 52
7.4 SAMPLE PROCESSING 53
7.5 SAMPLE COLLECTION AND TRANSPORTATION 54
8 STEM CELL BANKING MARKET, BY APPLICATION 56
8.1 INTRODUCTION 57
8.2 PERSONALIZED BANKING APPLICATIONS 58
8.3 RESEARCH APPLICATIONS 59
8.3.1 DISEASE TREATMENT STUDIES 60
8.3.2 LIFE SCIENCE RESEARCH 61
8.3.3 DRUG DISCOVERY 61
8.4 CLINICAL APPLICATIONS 62
8.4.1 HEMATOPOIETIC DISORDERS 63
8.4.2 AUTOIMMUNE DISORDERS 64
8.4.3 OTHER DISEASES 65
9 STEM CELL BANKING MARKET, BY REGION 67
9.1 INTRODUCTION 68
9.2 NORTH AMERICA 71
9.3 EUROPE 76
9.4 ASIA PACIFIC 81
9.5 ROW 85
10 COMPETITIVE LANDSCAPE 90
10.1 OVERVIEW 90
10.2 GLOBAL MARKET RANKING ANALYSIS (2017) 90
10.3 COMPETITIVE SCENARIO 91
10.3.1 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 91
10.3.2 MERGERS AND ACQUISITIONS 92
10.3.3 SERVICE LAUNCHES AND ENHANCEMENTS 93
10.3.4 OTHER DEVELOPMENTS 93
11 COMPANY PROFILE 94
(Overview, Services Offered, Recent Developments, MNM View)*
11.1 CORD BLOOD REGISTRY SYSTEMS 94
11.2 CORDLIFE 97
11.3 CRYO-CELL INTERNATIONAL 100
11.4 CRYO-SAVE AG (A SUBSIDIARY OF ESPERITE N.V) 102
11.5 LIFECELL INTERNATIONAL 104
11.6 STEMCYTE 106
11.7 VIACORD (A SUBSIDIARY OF PERKINELMER) 107
11.8 GLOBAL CORD BLOOD 109
11.9 SMART CELLS INTERNATIONAL 111
11.10 VITA34 112
11.11 CRYOHOLDCO 115
* Overview, Services Offered, Recent Developments, MNM View might not be captured in case of unlisted companies.
12 APPENDIX 116
12.1 DISCUSSION GUIDE* 116
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 120
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 122
12.4 AVAILABLE CUSTOMIZATIONS 122
12.5 RELATED REPORTS 123
12.6 AUTHOR DETAILS 124
